Massive Venlafaxine Overdose Resulted in a False Positive Abbott AxSYM® Urine Immunoassay for Phencyclidine

Journal of Toxicology - Clinical Toxicology

Volumn 41, Issue 7, 2003, Pages 999-1002

  Bond, G Randall ^a   Steele, Paul E ^a   Uges, Donald R A ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Abbott AxSYM immunoassay; Phencyclidine; Urine drug screen; Venlafaxine

Indexed keywords

ACTIVATED CARBON; AMPHETAMINE; BARBITURIC ACID DERIVATIVE; BENZAMYCIN; BENZODIAZEPINE DERIVATIVE; CANNABINOID; COCAINE; DESVENLAFAXINE; DEXTROMETHORPHAN; LORAZEPAM; OPIATE; PHENCYCLIDINE; PYRIDOXINE; VENLAFAXINE;

ADOLESCENT; ARTICLE; CASE REPORT; DEPRESSION; DRUG OVERDOSE; DRUG URINE LEVEL; FEMALE; GAS CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE TEST; LABORATORY DIAGNOSIS; MASS SPECTROMETRY; URINALYSIS;

ADOLESCENT; CYCLOHEXANOLS; DEPRESSION; FALSE POSITIVE REACTIONS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; IMMUNOASSAY; OVERDOSE; PHENCYCLIDINE;

EID: 0347995034     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.1081/CLT-120026525     Document Type: Article

References (10)

1. Shannon M. Ketamine induced false positive drug screen in a teen: unnecessary call to police and social services (letter). Ped Emerg Care 1998; 14:180.
2. Sena, SF, Kazimi S, Wu AH. False-positive phencyclidine immunoassay results caused by venlafaxine and O-desmethylvenlafaxine (letter). Clinical Chemistry 2002; 48(4):676-677.
3. Abbott Laboratories. Abbott AxSYM® system Phencyclidine 11 product insert July 1999.
4. Woo OF, Vrendenber M, Feitas P, Olson KR. Seizures after venlafaxine overdose: a case report (abstract). J Toxicol Clin Toxicol 1995; 33:549-550.
5. Troy SM, Parker VD, Fruncillo RJ, Chaing ST. The pharmacokinetics of venlafaxine when given in a twice-daily regimen. J Clin Pharmacol 1995; 35:404-409.
6. Sinegal M. Abbott Laboratories. Personal communication, phone call. September 19, 2002.
7. Youshock K, Pharm D. Manager, Global Product Information, Wyeth-Ayerst Pharmaceuticals. Personal communication, letter. April 23, 2001.
8. Rainey PM. Laboratory principles and techniques for the evaluation of the poisoned or overdosed patient. In: Goldfrank LR, Flomenbaum NE, Lewin NA, Howland MA, Hoffman RS, Nelson LS, eds. Goldfrank's Toxicologic Emergencies. 7th ed. New York: McGraw Hill, 2002:69-93.
9. Simone K, Bond GR. Detection of unusual abuse patterns using broad searching of the toxic exposure surveillance system (abstract). J Toxicol Clin Toxicol 2002; 40:657-658.
10. Simone K, Bond GR. Dextromethorphan: a successful example of monitoring for emerging ause using the toxic exposure surveillance system (abstract). J Toxicol Clin Toxicol 2002; 40:653-654.